95 related articles for article (PubMed ID: 10197412)
1. In-vivo evaluation of indium-111-diethylenetriaminepentaacetic acid-labelling for determining the sites and rates of protein catabolism in mice.
Mukai T; Arano Y; Nishida K; Sasaki H; Saji H; Nakamura J
J Pharm Pharmacol; 1999 Jan; 51(1):15-20. PubMed ID: 10197412
[TBL] [Abstract][Full Text] [Related]
2. Maleimidoethyl 3-(tri-n-butylstannyl)hippurate: a useful radioiodination reagent for protein radiopharmaceuticals to enhance target selective radioactivity localization.
Arano Y; Wakisaka K; Ohmomo Y; Uezono T; Mukai T; Motonari H; Shiono H; Sakahara H; Konishi J; Tanaka C
J Med Chem; 1994 Aug; 37(16):2609-18. PubMed ID: 8057303
[TBL] [Abstract][Full Text] [Related]
3. Disposition of radioactivity after injection of liver-targeted proteins labeled with 111In or 125I. Effect of labeling on distribution and excretion of radioactivity in rats.
Staud F; Nishikawa M; Morimoto K; Takakura Y; Hashida M
J Pharm Sci; 1999 Jun; 88(6):577-85. PubMed ID: 10350492
[TBL] [Abstract][Full Text] [Related]
4. A novel radioiodination reagent for protein radiopharmaceuticals with L-lysine as a plasma-stable metabolizable linkage to liberate m-iodohippuric acid after lysosomal proteolysis.
Wakisaka K; Arano Y; Uezono T; Akizawa H; Ono M; Kawai K; Ohomomo Y; Nakayama M; Saji H
J Med Chem; 1997 Aug; 40(16):2643-52. PubMed ID: 9258371
[TBL] [Abstract][Full Text] [Related]
5. A biological method to evaluate bifunctional chelating agents to label antibodies with metallic radionuclides.
Arano Y; Mukai T; Uezono T; Wakisaka K; Motonari H; Akizawa H; Taoka Y; Yokoyama A
J Nucl Med; 1994 May; 35(5):890-8. PubMed ID: 8176478
[TBL] [Abstract][Full Text] [Related]
6. Species difference in radioactivity elimination from liver parenchymal cells after injection of radiolabeled proteins.
Mukai T; Arano Y; Nishida K; Sasaki H; Akizawa H; Ogawa K; Ono M; Saji H; Nakamura J
Nucl Med Biol; 1999 Apr; 26(3):281-9. PubMed ID: 10363799
[TBL] [Abstract][Full Text] [Related]
7. Indirect labeling of macroaggregated albumin with indium-111 via diethylenetriaminepentaacetic acid.
Watanabe N; Shirakami Y; Tomiyoshi K; Oriuchi N; Hirano T; Yukihiro M; Inoue T; Endo K
Nucl Med Biol; 1996 Jul; 23(5):595-8. PubMed ID: 8905824
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic models to evaluate radiolabeling reagents for protein radiopharmaceuticals.
Mukai T; Arano Y; Nishida K; Sasaki H; Nakamura J; Saji H; Yokoyama A
Nucl Med Biol; 1998 Jan; 25(1):31-6. PubMed ID: 9466359
[TBL] [Abstract][Full Text] [Related]
9. Assessment of radiochemical design of antibodies using an ester bond as the metabolizable linkage: evaluation of maleimidoethyl 3-(tri-n-butylstannyl)hippurate as a radioiodination reagent of antibodies for diagnostic and therapeutic applications.
Arano Y; Wakisaka K; Ohmono Y; Uezono T; Akizawa H; Nakayama M; Sakahara H; Tanaka C; Konishi J; Yokoyama A
Bioconjug Chem; 1996; 7(6):628-37. PubMed ID: 8950481
[TBL] [Abstract][Full Text] [Related]
10. Improved kinetic stability of DTPA- dGlu as compared with conventional monofunctional DTPA in chelating indium and yttrium: preclinical and initial clinical evaluation of radiometal labelled minigastrin derivatives.
Béhé M; Becker W; Gotthardt M; Angerstein C; Behr TM
Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1140-6. PubMed ID: 12768330
[TBL] [Abstract][Full Text] [Related]
11. Development of radiolabelled albumin microspheres: a comparison of gamma-emitting radioisotopes of iodine (131I) and indium (111In/113mIn).
Willmott N; Murray T; Carlton R; Chen Y; Logan H; McCurrach G; Bessent RG; Goldberg JA; Anderson J; McKillop JH
Int J Rad Appl Instrum B; 1991; 18(7):687-94. PubMed ID: 1787077
[TBL] [Abstract][Full Text] [Related]
12. Radiolabeled metabolites of proteins play a critical role in radioactivity elimination from the liver.
Arano Y; Mukai T; Akizawa H; Uezono T; Motonari H; Wakisaka K; Kairiyama C; Yokoyama A
Nucl Med Biol; 1995 Jul; 22(5):555-64. PubMed ID: 7581163
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of a monoreactive DOTA derivative for indium-111-based residualizing label to estimate protein pharmacokinetics.
Mukai T; Namba S; Arano Y; Ono M; Fujioka Y; Uehara T; Ogawa K; Konishi J; Saji H
J Pharm Pharmacol; 2002 Aug; 54(8):1073-81. PubMed ID: 12195821
[TBL] [Abstract][Full Text] [Related]
14. Comparison of three remote radiolabelling methods for long-circulating liposomes.
van der Geest T; Laverman P; Gerrits D; Franssen GM; Metselaar JM; Storm G; Boerman OC
J Control Release; 2015 Dec; 220(Pt A):239-244. PubMed ID: 26514291
[TBL] [Abstract][Full Text] [Related]
15. Indium-111-diethylenetriaminepentaacetic acid-octreotide is delivered in vivo to pancreatic, tumor cell, renal, and hepatocyte lysosomes.
Duncan JR; Stephenson MT; Wu HP; Anderson CJ
Cancer Res; 1997 Feb; 57(4):659-71. PubMed ID: 9044843
[TBL] [Abstract][Full Text] [Related]
16. Gallium-labeled deferoxamine-galactosyl-neoglycoalbumin: a radiopharmaceutical for regional measurement of hepatic receptor biochemistry.
Vera DR
J Nucl Med; 1992 Jun; 33(6):1160-6. PubMed ID: 1597732
[TBL] [Abstract][Full Text] [Related]
17. Uptake of indium-111 in the liver of mice following administration of indium-111-DTPA-labeled monoclonal antibodies: influence of labeling parameters, physiologic parameters, and antibody dose.
Schuhmacher J; Klivényi G; Matys R; Kirchgebner H; Hauser H; Maier-Borst W; Matzku S
J Nucl Med; 1990 Jun; 31(6):1084-93. PubMed ID: 2348237
[TBL] [Abstract][Full Text] [Related]
18. Fluorine-18 labeled galactosyl-neoglycoalbumin for imaging the hepatic asialoglycoprotein receptor.
Yang W; Mou T; Peng C; Wu Z; Zhang X; Li F; Ma Y
Bioorg Med Chem; 2009 Nov; 17(21):7510-6. PubMed ID: 19796957
[TBL] [Abstract][Full Text] [Related]
19. Specific localization, gamma camera imaging, and intracellular trafficking of radiolabelled chimeric anti-G(D3) ganglioside monoclonal antibody KM871 in SK-MEL-28 melanoma xenografts.
Lee FT; Rigopoulos A; Hall C; Clarke K; Cody SH; Smyth FE; Liu Z; Brechbiel MW; Hanai N; Nice EC; Catimel B; Burgess AW; Welt S; Ritter G; Old LJ; Scott AM
Cancer Res; 2001 Jun; 61(11):4474-82. PubMed ID: 11389078
[TBL] [Abstract][Full Text] [Related]
20. Stabilised 111In-labelled DTPA- and DOTA-conjugated neurotensin analogues for imaging and therapy of exocrine pancreatic cancer.
de Visser M; Janssen PJ; Srinivasan A; Reubi JC; Waser B; Erion JL; Schmidt MA; Krenning EP; de Jong M
Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1134-9. PubMed ID: 12768332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
